Purchase of 3,000 shares at $12.91 per share.
Reporting Person Cavers Greg · Officer Title Chief Financial Officer · Transaction Code P
Traded Sep 29, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0000912282-26-001334 · filed 2026-10-01 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Helus Pharma Inc. (HELP)." Disclosed 2026-10-01. https://desqlong.com/cards/0000912282-26-001334-1 (retrieved 2026-10-02).